U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 438

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr17:29654751
GRCh38:
Chr17:31327733
NF1Q1814K, Q1835KJuvenile myelomonocytic leukemia, Neurofibromatosis, type 1, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal
Uncertain significance
(Mar 30, 2021)
criteria provided, single submitter
2.
GRCh37:
Chr17:29667674-29667675
GRCh38:
Chr17:31340656-31340657
NF1Neurofibromatosis, type 1, Neurofibromatosis, familial spinal, Juvenile myelomonocytic leukemia,
Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis
Likely benign
(Oct 29, 2022)
criteria provided, multiple submitters, no conflicts
3.
GRCh37:
Chr17:29654499
GRCh38:
Chr17:31327481
NF1Neurofibromatosis, type 1, Neurofibromatosis, familial spinal, Juvenile myelomonocytic leukemia,
Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, type 1
Likely benign
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
4.
GRCh37:
Chr17:29592371
GRCh38:
Chr17:31265353
NF1Neurofibromatosis, type 1, Neurofibromatosis, familial spinal, Juvenile myelomonocytic leukemia,
Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis
Likely benign
(Oct 1, 2022)
criteria provided, multiple submitters, no conflicts
5.
GRCh37:
Chr17:29482982
GRCh38:
Chr17:31155964
NF1Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, familial spinal,
Juvenile myelomonocytic leukemia, Neurofibromatosis, type 1, Neurofibromatosis, type 1
Likely benign
(Nov 30, 2021)
criteria provided, multiple submitters, no conflicts
6.
GRCh37:
Chr17:29562918
GRCh38:
Chr17:31235900
NF1Neurofibromatosis, familial spinal, Juvenile myelomonocytic leukemia, Neurofibromatosis, type 1,
Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, type 1
Likely benign
(Oct 16, 2022)
criteria provided, multiple submitters, no conflicts
7.
GRCh37:
Chr17:29528417
GRCh38:
Chr17:31201399
NF1Neurofibromatosis, familial spinal, Juvenile myelomonocytic leukemia, Neurofibromatosis, type 1,
Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, type 1
Likely benign
(Oct 8, 2022)
criteria provided, multiple submitters, no conflicts
8.
GRCh37:
Chr17:29559913
GRCh38:
Chr17:31232895
NF1Neurofibromatosis, type 1, Neurofibromatosis, familial spinal, Juvenile myelomonocytic leukemia,
Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, type 1
Likely benign
(Aug 2, 2022)
criteria provided, multiple submitters, no conflicts
9.
GRCh37:
Chr17:29592370
GRCh38:
Chr17:31265352
NF1Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome,
Neurofibromatosis, familial spinal, Juvenile myelomonocytic leukemia, Neurofibromatosis, type 1
Likely benign
(Oct 26, 2022)
criteria provided, multiple submitters, no conflicts
10.
GRCh37:
Chr17:29684403
GRCh38:
Chr17:31357385
NF1Juvenile myelomonocytic leukemia, Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome,
Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, familial spinal, Neurofibromatosis, type 1
Likely benign
(Sep 15, 2022)
criteria provided, multiple submitters, no conflicts
11.
GRCh37:
Chr17:29560242
GRCh38:
Chr17:31233224
NF1Neurofibromatosis, type 1, Neurofibromatosis, familial spinal, Juvenile myelomonocytic leukemia,
Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis
Likely benign
(Jun 12, 2022)
criteria provided, multiple submitters, no conflicts
12.
GRCh37:
Chr17:29554218
GRCh38:
Chr17:31227200
NF1Neurofibromatosis-Noonan syndrome, Juvenile myelomonocytic leukemia, Neurofibromatosis, type 1,
Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, familial spinal, Neurofibromatosis, type 1
Likely benign
(Oct 11, 2022)
criteria provided, multiple submitters, no conflicts
13.
GRCh37:
Chr17:29576152
GRCh38:
Chr17:31249134
NF1Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome, Juvenile myelomonocytic leukemia,
Neurofibromatosis, type 1, Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, familial spinal
Likely benign
(Aug 16, 2022)
criteria provided, multiple submitters, no conflicts
14.
GRCh37:
Chr17:29422398
GRCh38:
Chr17:31095380
LOC111811965, MIR4733HG, NF1Neurofibromatosis, type 1, Juvenile myelomonocytic leukemia, Neurofibromatosis, familial spinal,
Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, type 1
Likely benign
(Oct 31, 2022)
criteria provided, multiple submitters, no conflicts
15.
GRCh37:
Chr17:29654498
GRCh38:
Chr17:31327480
NF1Neurofibromatosis, familial spinal, Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis, type 1, Juvenile myelomonocytic leukemia, Neurofibromatosis, type 1
Likely benign
(Nov 2, 2022)
criteria provided, multiple submitters, no conflicts
16.
GRCh37:
Chr17:29509510
GRCh38:
Chr17:31182492
NF1Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, familial spinal,
Neurofibromatosis, type 1, Juvenile myelomonocytic leukemia, Neurofibromatosis, type 1
Likely benign
(Oct 13, 2021)
criteria provided, multiple submitters, no conflicts
17.
GRCh37:
Chr17:29652874
GRCh38:
Chr17:31325856
NF1Juvenile myelomonocytic leukemia, Neurofibromatosis, familial spinal, Neurofibromatosis, type 1,
Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, type 1
Likely benign
(Nov 9, 2021)
criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr17:29661844
GRCh38:
Chr17:31334826
NF1Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal,
Café-au-lait macules with pulmonary stenosis, Juvenile myelomonocytic leukemia, Neurofibromatosis, type 1
Likely benign
(Aug 8, 2022)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr17:29679451
GRCh38:
Chr17:31352433
NF1Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal,
Café-au-lait macules with pulmonary stenosis, Juvenile myelomonocytic leukemia, Neurofibromatosis, type 1
Likely benign
(Oct 18, 2022)
criteria provided, multiple submitters, no conflicts
20.
GRCh37:
Chr17:29508420
GRCh38:
Chr17:31181402
NF1Juvenile myelomonocytic leukemia, Neurofibromatosis, type 1, Neurofibromatosis, familial spinal,
Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, type 1
Likely benign
(Aug 31, 2022)
criteria provided, multiple submitters, no conflicts
21.
GRCh37:
Chr17:29665798
GRCh38:
Chr17:31338780
NF1K2279fs, K2300fsJuvenile myelomonocytic leukemia, Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal,
Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, type 1
Pathogenic
(Sep 30, 2021)
criteria provided, multiple submitters, no conflicts
22.
GRCh37:
Chr17:29548953
GRCh38:
Chr17:31221935
NF1M576TJuvenile myelomonocytic leukemia, Neurofibromatosis, familial spinal, Neurofibromatosis, type 1,
Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, type 1
Uncertain significance
(May 27, 2022)
criteria provided, multiple submitters, no conflicts
23.
GRCh37:
Chr17:29670077
GRCh38:
Chr17:31343059
NF1Juvenile myelomonocytic leukemia, Neurofibromatosis, familial spinal, Neurofibromatosis, type 1,
Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, type 1
Uncertain significance
(Apr 28, 2022)
criteria provided, multiple submitters, no conflicts
24.
GRCh37:
Chr17:29528197
GRCh38:
Chr17:31201179
NF1Neurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis, Juvenile myelomonocytic leukemia,
Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome, Neurofibromatosis, type 1
Conflicting interpretations of pathogenicity
(Oct 17, 2022)
criteria provided, conflicting interpretations
25.
GRCh37:
Chr17:29587393
GRCh38:
Chr17:31260375
NF1F1458L, F1479LNeurofibromatosis, familial spinal, Juvenile myelomonocytic leukemia, Neurofibromatosis, type 1,
Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, type 1
Uncertain significance
(Mar 23, 2022)
criteria provided, multiple submitters, no conflicts
26.
GRCh37:
Chr17:29654838
GRCh38:
Chr17:31327820
NF1S1843C, S1864CNeurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis, familial spinal, Juvenile myelomonocytic leukemia, Neurofibromatosis, type 1
Uncertain significance
(Oct 27, 2021)
criteria provided, multiple submitters, no conflicts
27.
GRCh37:
Chr17:29670042
GRCh38:
Chr17:31343024
NF1F2339L, F2360LJuvenile myelomonocytic leukemia, Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome,
Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, familial spinal, Neurofibromatosis, type 1
Uncertain significance
(Dec 6, 2021)
criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr17:29662066
GRCh38:
Chr17:31335048
NF1Neurofibromatosis, type 1, Juvenile myelomonocytic leukemia, Neurofibromatosis, familial spinal,
Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis
Likely benign
(Oct 19, 2022)
criteria provided, multiple submitters, no conflicts
29.
GRCh37:
Chr17:29663338-29663340
GRCh38:
Chr17:31336320-31336322
NF1Neurofibromatosis, familial spinal, Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis,
Juvenile myelomonocytic leukemia, Neurofibromatosis, type 1, Neurofibromatosis, type 1
Likely benign
(Oct 8, 2022)
criteria provided, multiple submitters, no conflicts
30.
GRCh37:
Chr17:29592280
GRCh38:
Chr17:31265262
NF1Neurofibromatosis, type 1, Juvenile myelomonocytic leukemia, Neurofibromatosis, type 1,
Neurofibromatosis, familial spinal, Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis
Pathogenic/Likely pathogenic
(Oct 4, 2021)
criteria provided, multiple submitters, no conflicts
31.
GRCh37:
Chr17:29701156
GRCh38:
Chr17:31374138
NF1I2814V, I2835VNeurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis, Juvenile myelomonocytic leukemia,
Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome, Neurofibromatosis, type 1
Uncertain significance
(Apr 7, 2022)
criteria provided, multiple submitters, no conflicts
32.
GRCh37:
Chr17:29652981-29652982
GRCh38:
Chr17:31325963-31325964
NF1K1661*, K1640*not provided, Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis,
Juvenile myelomonocytic leukemia, Neurofibromatosis, familial spinal, Neurofibromatosis, type 1,
Neurofibromatosis, type 1
Pathogenic/Likely pathogenic
(Dec 2, 2022)
criteria provided, multiple submitters, no conflicts
33.
GRCh37:
Chr17:29683591
GRCh38:
Chr17:31356573
NF1Y2577H, Y2556HNeurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, familial spinal,
Juvenile myelomonocytic leukemia, Neurofibromatosis, type 1, Neurofibromatosis, type 1
Uncertain significance
(Dec 27, 2021)
criteria provided, multiple submitters, no conflicts
34.
GRCh37:
Chr17:29653080
GRCh38:
Chr17:31326062
NF1H1672R, H1693RNeurofibromatosis, familial spinal, Juvenile myelomonocytic leukemia, Neurofibromatosis, type 1,
Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis, not provided
Uncertain significance
(Feb 17, 2023)
criteria provided, multiple submitters, no conflicts
35.
GRCh37:
Chr17:29585340
GRCh38:
Chr17:31258322
NF1Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome
Uncertain significance
(Feb 5, 2021)
criteria provided, single submitter
36.
GRCh37:
Chr17:29665822
GRCh38:
Chr17:31338804
NF1K2286R, K2307RNeurofibromatosis, type 1, Neurofibromatosis, familial spinal, Juvenile myelomonocytic leukemia,
Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis,
not provided
Uncertain significance
(Jun 10, 2022)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr17:29552144
GRCh38:
Chr17:31225126
NF1Y628fsCafé-au-lait macules with pulmonary stenosis, Neurofibromatosis, type 1Pathogenic
(Sep 23, 2020)
criteria provided, single submitter
38.
GRCh37:
Chr17:29665168
GRCh38:
Chr17:31338150
NF1Hereditary cancer-predisposing syndrome, not provided, Neurofibromatosis, familial spinal,
Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis, Juvenile myelomonocytic leukemia,
Neurofibromatosis, type 1, Neurofibromatosis, type 1, Hereditary cancer-predisposing syndrome,
Cardiovascular phenotype
Benign/Likely benign
(Apr 1, 2023)
criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr17:29527429-29527434
GRCh38:
Chr17:31200411-31200416
NF1Neurofibromatosis, type 1, Neurofibromatosis, familial spinal, Juvenile myelomonocytic leukemia,
Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis, not provided
Uncertain significance
(Mar 31, 2022)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr17:29685481-29685482
GRCh38:
Chr17:31358463-31358464
NF1Neurofibromatosis, type 1, not provided, Neurofibromatosis, familial spinal,
Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, type 1,
Juvenile myelomonocytic leukemia
Benign/Likely benign
(Oct 31, 2022)
criteria provided, multiple submitters, no conflicts
41.
GRCh37:
Chr17:29552274-29552276
GRCh38:
Chr17:31225256-31225258
NF1Neurofibromatosis, type 1, Juvenile myelomonocytic leukemia, Neurofibromatosis-Noonan syndrome,
Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, familial spinal, Neurofibromatosis, type 1
Likely benign
(Aug 23, 2022)
criteria provided, multiple submitters, no conflicts
42.
GRCh37:
Chr17:29663464
GRCh38:
Chr17:31336446
NF1Hereditary cancer-predisposing syndrome, Cardiovascular phenotype, Neurofibromatosis-Noonan syndrome,
Café-au-lait macules with pulmonary stenosis, Juvenile myelomonocytic leukemia, Neurofibromatosis, type 1,
Neurofibromatosis, familial spinal, Neurofibromatosis, type 1
Likely benign
(Dec 5, 2021)
criteria provided, multiple submitters, no conflicts
43.
GRCh37:
Chr17:29556327
GRCh38:
Chr17:31229309
NF1Cardiovascular phenotype, Hereditary cancer-predisposing syndrome, Juvenile myelomonocytic leukemia,
Neurofibromatosis, familial spinal, Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis, type 1, Neurofibromatosis, type 1
Likely benign
(Jul 25, 2022)
criteria provided, multiple submitters, no conflicts
44.
GRCh37:
Chr17:29556219
GRCh38:
Chr17:31229201
NF1Neurofibromatosis, type 1, Neurofibromatosis, type 1, Neurofibromatosis, familial spinal,
Juvenile myelomonocytic leukemia, Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis
Likely benign
(Dec 30, 2021)
criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr17:29560151
GRCh38:
Chr17:31233133
NF1E1210*Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis, familial spinal, Juvenile myelomonocytic leukemia, Neurofibromatosis, type 1
Pathogenic
(May 20, 2022)
criteria provided, multiple submitters, no conflicts
46.
GRCh37:
Chr17:29588791
GRCh38:
Chr17:31261773
NF1G1526D, G1547DNeurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis, familial spinal, Juvenile myelomonocytic leukemia, Neurofibromatosis, type 1
Uncertain significance
(May 31, 2022)
criteria provided, multiple submitters, no conflicts
47.
GRCh37:
Chr17:29654554
GRCh38:
Chr17:31327536
NF1R1748P, R1769PCafé-au-lait macules with pulmonary stenosisUncertain significance
(Jun 19, 2018)
criteria provided, single submitter
48.
GRCh37:
Chr17:29586095
GRCh38:
Chr17:31259077
NF1H1439D, H1460Dnot provided, Café-au-lait macules with pulmonary stenosisUncertain significance
(Nov 30, 2020)
criteria provided, multiple submitters, no conflicts
49.
GRCh37:
Chr17:29587409
GRCh38:
Chr17:31260391
NF1D1464Y, D1485YNeurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis, Juvenile myelomonocytic leukemia,
Neurofibromatosis, type 1, Neurofibromatosis, familial spinal, Neurofibromatosis, type 1
Uncertain significance
(Mar 1, 2022)
criteria provided, multiple submitters, no conflicts
50.
GRCh37:
Chr17:29554277
GRCh38:
Chr17:31227259
NF1R765CJuvenile myelomonocytic leukemia, Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome,
Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, familial spinal, Hereditary cancer-predisposing syndrome,
Cardiovascular phenotype, Neurofibromatosis, type 1
Uncertain significance
(Aug 1, 2022)
criteria provided, multiple submitters, no conflicts
51.
GRCh37:
Chr17:29665160
GRCh38:
Chr17:31338142
NF1Hereditary cancer-predisposing syndrome, Juvenile myelomonocytic leukemia, Neurofibromatosis, type 1,
Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis
Likely pathogenic
(Dec 6, 2021)
criteria provided, multiple submitters, no conflicts
52.
GRCh37:
Chr17:29685177
GRCh38:
Chr17:31358159
NF1Neurofibromatosis, type 1, Juvenile myelomonocytic leukemia, Neurofibromatosis, familial spinal,
Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis
Pathogenic/Likely pathogenic
(Aug 9, 2022)
criteria provided, multiple submitters, no conflicts
53.
GRCh37:
Chr17:29509685
GRCh38:
Chr17:31182667
NF1Neurofibromatosis, type 1, not providedPathogenic
(May 4, 2023)
criteria provided, multiple submitters, no conflicts
54.
GRCh37:
Chr17:29701367
GRCh38:
Chr17:31374349
NF1Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis, type 1
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
55.
GRCh37:
Chr17:29701333
GRCh38:
Chr17:31374315
NF1Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis, type 1
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
56.
GRCh37:
Chr17:29703950
GRCh38:
Chr17:31376932
NF1Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis, type 1
Benign
(Jan 13, 2018)
criteria provided, single submitter
57.
GRCh37:
Chr17:29422077
GRCh38:
Chr17:31095059
LOC111811965, MIR4733HG, NF1Neurofibromatosis, familial spinal, Neurofibromatosis-Noonan syndrome, Neurofibromatosis, type 1,
Café-au-lait macules with pulmonary stenosis
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
58.
GRCh37:
Chr17:29422063
GRCh38:
Chr17:31095045
LOC111811965, MIR4733HG, NF1Neurofibromatosis, familial spinal, Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis, type 1
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
59.
GRCh37:
Chr17:29702654
GRCh38:
Chr17:31375636
NF1Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis, type 1
Benign
(Jan 13, 2018)
criteria provided, single submitter
60.
GRCh37:
Chr17:29702323
GRCh38:
Chr17:31375305
NF1Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis, type 1
Uncertain significance
(Apr 27, 2017)
criteria provided, single submitter
61.
GRCh37:
Chr17:29701758
GRCh38:
Chr17:31374740
NF1Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis, type 1
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
62.
GRCh37:
Chr17:29702652
GRCh38:
Chr17:31375634
NF1Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis, type 1
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
63.
GRCh37:
Chr17:29702144
GRCh38:
Chr17:31375126
NF1Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis, type 1
Benign
(Jan 12, 2018)
criteria provided, single submitter
64.
GRCh37:
Chr17:29702060
GRCh38:
Chr17:31375042
NF1Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis, type 1
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
65.
GRCh37:
Chr17:29701757
GRCh38:
Chr17:31374739
NF1Neurofibromatosis, familial spinal, Neurofibromatosis-Noonan syndrome, Neurofibromatosis, type 1,
Café-au-lait macules with pulmonary stenosis
Conflicting interpretations of pathogenicity
(Apr 27, 2017)
criteria provided, conflicting interpretations
66.
GRCh37:
Chr17:29701755
GRCh38:
Chr17:31374737
NF1Neurofibromatosis, type 1, Café-au-lait macules with pulmonary stenosis, not provided,
Neurofibromatosis, familial spinal, Neurofibromatosis-Noonan syndrome
Benign/Likely benign
(May 1, 2023)
criteria provided, multiple submitters, no conflicts
67.
GRCh37:
Chr17:29701299
GRCh38:
Chr17:31374281
NF1Neurofibromatosis, familial spinal, Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis, type 1, not provided
Conflicting interpretations of pathogenicity
(Jun 1, 2023)
criteria provided, conflicting interpretations
68.
GRCh37:
Chr17:29701297
GRCh38:
Chr17:31374279
NF1Neurofibromatosis, familial spinal, Neurofibromatosis-Noonan syndrome, Neurofibromatosis, type 1,
Café-au-lait macules with pulmonary stenosis
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
69.
GRCh37:
Chr17:29533395
GRCh38:
Chr17:31206377
NF1Hereditary cancer-predisposing syndrome, Neurofibromatosis, familial spinal, Neurofibromatosis-Noonan syndrome,
Neurofibromatosis, type 1, Café-au-lait macules with pulmonary stenosis
Conflicting interpretations of pathogenicity
(Aug 8, 2022)
criteria provided, conflicting interpretations
70.
GRCh37:
Chr17:29486093
GRCh38:
Chr17:31159075
NF1Neurofibromatosis, type 1, Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, familial spinal,
Neurofibromatosis-Noonan syndrome
Uncertain significance
(Oct 20, 2022)
criteria provided, multiple submitters, no conflicts
71.
GRCh37:
Chr17:29704400
GRCh38:
Chr17:31377382
NF1Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, type 1, Neurofibromatosis, familial spinal,
Neurofibromatosis-Noonan syndrome
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
72.
GRCh37:
Chr17:29704362
GRCh38:
Chr17:31377344
NF1Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, type 1, Neurofibromatosis, familial spinal,
Neurofibromatosis-Noonan syndrome
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
73.
GRCh37:
Chr17:29422162
GRCh38:
Chr17:31095144
LOC111811965, MIR4733HG, NF1Neurofibromatosis, familial spinal, Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis, type 1
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
74.
GRCh37:
Chr17:29421965
GRCh38:
Chr17:31094947
LOC111811965, MIR4733HG, NF1Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, familial spinal, Neurofibromatosis-Noonan syndrome,
Neurofibromatosis, type 1
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
75.
GRCh37:
Chr17:29575990
GRCh38:
Chr17:31248972
NF1Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome,
Neurofibromatosis, familial spinal
Benign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
76.
GRCh37:
Chr17:29704687
GRCh38:
Chr17:31377669
NF1Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome,
Neurofibromatosis, familial spinal
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
77.
GRCh37:
Chr17:29703713
GRCh38:
Chr17:31376695
NF1Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome,
Neurofibromatosis, familial spinal
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
78.
GRCh37:
Chr17:29703246
GRCh38:
Chr17:31376228
NF1Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome,
Neurofibromatosis, familial spinal
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
79.
GRCh37:
Chr17:29702381
GRCh38:
Chr17:31375363
NF1Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome,
Neurofibromatosis, familial spinal
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
80.
GRCh37:
Chr17:29701714
GRCh38:
Chr17:31374696
NF1Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, type 1, Neurofibromatosis, familial spinal,
Neurofibromatosis-Noonan syndrome
Benign/Likely benign
(Jan 12, 2018)
criteria provided, single submitter
81.
GRCh37:
Chr17:29701274
GRCh38:
Chr17:31374256
NF1Neurofibromatosis, type 1, Neurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis-Noonan syndrome
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
82.
GRCh37:
Chr17:29683463
GRCh38:
Chr17:31356445
NF1Neurofibromatosis, type 1, Neurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis-Noonan syndrome
Conflicting interpretations of pathogenicity
(Oct 8, 2022)
criteria provided, conflicting interpretations
83.
GRCh37:
Chr17:29704687
GRCh38:
Chr17:31377669
NF1not provided, Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis, familial spinal, Neurofibromatosis, type 1
Benign/Likely benign
(Jan 1, 2023)
criteria provided, multiple submitters, no conflicts
84.
GRCh37:
Chr17:29422277
GRCh38:
Chr17:31095259
LOC111811965, MIR4733HG, NF1Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, familial spinal,
Neurofibromatosis, type 1
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
85.
GRCh37:
Chr17:29703420
GRCh38:
Chr17:31376402
NF1Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, type 1, Neurofibromatosis, familial spinal,
Neurofibromatosis-Noonan syndrome
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
86.
GRCh37:
Chr17:29703183
GRCh38:
Chr17:31376165
NF1Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, type 1, Neurofibromatosis, familial spinal,
Neurofibromatosis-Noonan syndrome
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
87.
GRCh37:
Chr17:29702360
GRCh38:
Chr17:31375342
NF1Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, type 1, Neurofibromatosis, familial spinal,
Neurofibromatosis-Noonan syndrome
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
88.
GRCh37:
Chr17:29701758
GRCh38:
Chr17:31374740
NF1not provided, Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis, familial spinal, Neurofibromatosis, type 1
Benign/Likely benign
(Jan 1, 2023)
criteria provided, multiple submitters, no conflicts
89.
GRCh37:
Chr17:29701558
GRCh38:
Chr17:31374540
NF1Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, type 1, Neurofibromatosis, familial spinal,
Neurofibromatosis-Noonan syndrome
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
90.
GRCh37:
Chr17:29664824
GRCh38:
Chr17:31337806
NF1not provided, Neurofibromatosis, familial spinal, Neurofibromatosis-Noonan syndrome,
Neurofibromatosis, type 1, Café-au-lait macules with pulmonary stenosis
Conflicting interpretations of pathogenicity
(Oct 26, 2022)
criteria provided, conflicting interpretations
91.
GRCh37:
Chr17:29554639
GRCh38:
Chr17:31227621
NF1Neurofibromatosis-Noonan syndrome, Neurofibromatosis, type 1, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis, familial spinal
Conflicting interpretations of pathogenicity
(Dec 30, 2021)
criteria provided, conflicting interpretations
92.
GRCh37:
Chr17:29687701
GRCh38:
Chr17:31360683
NF1A2786V, A2765VNeurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis,
Juvenile myelomonocytic leukemia, Neurofibromatosis, familial spinal, Neurofibromatosis, type 1,
not provided
Uncertain significance
(Jul 22, 2022)
criteria provided, multiple submitters, no conflicts
93.
GRCh37:
Chr17:29684020
GRCh38:
Chr17:31357002
NF1R2594L, R2573LNeurofibromatosis, type 1, Neurofibromatosis, familial spinal, Neurofibromatosis-Noonan syndrome,
Café-au-lait macules with pulmonary stenosis, Juvenile myelomonocytic leukemia, Neurofibromatosis, type 1,
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype
Conflicting interpretations of pathogenicity
(Oct 24, 2022)
criteria provided, conflicting interpretations
94.
GRCh37:
Chr17:29679340
GRCh38:
Chr17:31352322
NF1Y2508C, Y2487CHereditary cancer-predisposing syndrome, Cardiovascular phenotype, Neurofibromatosis, type 1,
Neurofibromatosis, familial spinal, Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis,
Juvenile myelomonocytic leukemia, Neurofibromatosis, type 1
Uncertain significance
(May 6, 2022)
criteria provided, multiple submitters, no conflicts
95.
GRCh37:
Chr17:29665789
GRCh38:
Chr17:31338771
NF1I2296T, I2275TNeurofibromatosis, type 1, Neurofibromatosis, familial spinal, Neurofibromatosis-Noonan syndrome,
Café-au-lait macules with pulmonary stenosis, Juvenile myelomonocytic leukemia, Neurofibromatosis, type 1,
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype
Uncertain significance
(May 31, 2022)
criteria provided, multiple submitters, no conflicts
96.
GRCh37:
Chr17:29664588
GRCh38:
Chr17:31337570
NF1L2210F, L2189FNeurofibromatosis, familial spinal, Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis,
Juvenile myelomonocytic leukemia, Neurofibromatosis, type 1, Hereditary cancer-predisposing syndrome,
Cardiovascular phenotype
Uncertain significance
(Apr 27, 2022)
criteria provided, multiple submitters, no conflicts
97.
GRCh37:
Chr17:29585427
GRCh38:
Chr17:31258409
NF1F1392L, F1413LHereditary cancer-predisposing syndrome, Cardiovascular phenotype, Neurofibromatosis, type 1,
Neurofibromatosis, familial spinal, Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis,
Juvenile myelomonocytic leukemia, Neurofibromatosis, type 1
Uncertain significance
(Mar 15, 2022)
criteria provided, multiple submitters, no conflicts
98.
GRCh37:
Chr17:29576102
GRCh38:
Chr17:31249084
NF1P1359THereditary cancer-predisposing syndrome, Cardiovascular phenotype, Neurofibromatosis, familial spinal,
Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis, Juvenile myelomonocytic leukemia,
Neurofibromatosis, type 1
Uncertain significance
(Mar 2, 2022)
criteria provided, multiple submitters, no conflicts
99.
GRCh37:
Chr17:29576101
GRCh38:
Chr17:31249083
NF1Hereditary cancer-predisposing syndrome, Cardiovascular phenotype, Neurofibromatosis, familial spinal,
Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis, Juvenile myelomonocytic leukemia,
Neurofibromatosis, type 1
Likely benign
(Mar 2, 2022)
criteria provided, multiple submitters, no conflicts
100.
GRCh37:
Chr17:29701059
GRCh38:
Chr17:31374041
NF1Neurofibromatosis, familial spinal, Juvenile myelomonocytic leukemia, Neurofibromatosis-Noonan syndrome,
Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, type 1, Cardiovascular phenotype,
Hereditary cancer-predisposing syndrome
Likely benign
(Nov 1, 2021)
criteria provided, multiple submitters, no conflicts
Format
Items per page
Sort by
Choose Destination